Troy Ignelzi

Mr. Troy A. Ignelzi is an Independent Director at Harmony Biosciences Holdings, Inc., an Independent Director at Contineum Therapeutics, Inc., a Chief Financial Officer at Rapport Therapeutics, Inc., an Executive Advisor at Sofinnova Investments, Inc. and an Independent Director at Abivax SA. He is on the Board of Directors at Harmony Biosciences Holdings, Inc., Contineum Therapeutics, Inc. and Abivax SA. Mr. Ignelzi was previously employed as an Independent Director by CinCor Pharma, Inc., a Chairman by Vedanta Biosciences, Inc., a Chief Financial Officer by Karuna Therapeutics, Inc., a Chief Financial & Accounting Officer by scPharmaceuticals, Inc., a Chief Financial Officer by Juventas Therapeutics, Inc., a Senior VP-Operations & Business Development by PharmaLex GmbH, a Vice President by Esperion Therapeutics, Inc., and a VP-Business Development & Strategic Planning by InSys Therapeutics, Inc. /Old/.
He received his undergraduate degree from Ferris State University (Michigan).